Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?

Detalhes bibliográficos
Autor(a) principal: Liberalesso,Paulo Breno Noronha
Data de Publicação: 2008
Outros Autores: Nascimento,Lincoln Franscisco, Klagenberg,Karlin Fabianne, Jurkiewicz,Ari Leon, Zeigelboim,Bianca Simone
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of epilepsy and clinical neurophysiology (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009
Resumo: INTRODUCTION: Landau-Kleffner Syndrome is a rare epileptic syndrome characterized by the association of receptive aphasia, epileptic seizures, behavioral disorders and electroencephalographic changes with discharges at the temporal lobe unilaterally or bilaterally. Seizures are not essential for diagnosis. CASE REPORT: J. V. S. S., 3 y/o male, with delay in acquirement of speech, psychomotor agitation and sleep disorder (sleeplessness). Attempt to communicate was established by gestures and pointing at things. His behavior characterized by agitation, restlessness, aggressiveness and difficulty to establish social contact with other children by the same age. MRI was normal and the EEG showed sharp-wave discharges in the left medial and posterior temporal regions. After three months of treatment with carbamazepine the child returned to an evaluation, presenting substantial improvement at speech, speaking simple words and with meaningful improvement on both behavioral and sleep patterns, as well as, social interaction. DISCUSSION: Expression and reception speech disorders are relatively common in children with different epileptic syndromes, particularly in Landau-Kleffner syndrome. Epileptiform discharges can occur in people without epilepsy and use to be called subclinical discharges. What would be the impact of subclinical discharges on this population remains uncertain at the present time. We reviewed these interactions in the light of a representative case, showing favorable outcome following introduction of an antiepileptic drug.
id LBE-1_4860e7675c651cce918f404811e83c9a
oai_identifier_str oai:scielo:S1676-26492008000300009
network_acronym_str LBE-1
network_name_str Journal of epilepsy and clinical neurophysiology (Online)
repository_id_str
spelling Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?Subclinical dischargesLandau-Kleffner Syndromespeech delayINTRODUCTION: Landau-Kleffner Syndrome is a rare epileptic syndrome characterized by the association of receptive aphasia, epileptic seizures, behavioral disorders and electroencephalographic changes with discharges at the temporal lobe unilaterally or bilaterally. Seizures are not essential for diagnosis. CASE REPORT: J. V. S. S., 3 y/o male, with delay in acquirement of speech, psychomotor agitation and sleep disorder (sleeplessness). Attempt to communicate was established by gestures and pointing at things. His behavior characterized by agitation, restlessness, aggressiveness and difficulty to establish social contact with other children by the same age. MRI was normal and the EEG showed sharp-wave discharges in the left medial and posterior temporal regions. After three months of treatment with carbamazepine the child returned to an evaluation, presenting substantial improvement at speech, speaking simple words and with meaningful improvement on both behavioral and sleep patterns, as well as, social interaction. DISCUSSION: Expression and reception speech disorders are relatively common in children with different epileptic syndromes, particularly in Landau-Kleffner syndrome. Epileptiform discharges can occur in people without epilepsy and use to be called subclinical discharges. What would be the impact of subclinical discharges on this population remains uncertain at the present time. We reviewed these interactions in the light of a representative case, showing favorable outcome following introduction of an antiepileptic drug.Liga Brasileira de Epilepsia (LBE)2008-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009Journal of Epilepsy and Clinical Neurophysiology v.14 n.3 2008reponame:Journal of epilepsy and clinical neurophysiology (Online)instname:Liga Brasileira de Epilepsia (LBE)instacron:LBE10.1590/S1676-26492008000300009info:eu-repo/semantics/openAccessLiberalesso,Paulo Breno NoronhaNascimento,Lincoln FransciscoKlagenberg,Karlin FabianneJurkiewicz,Ari LeonZeigelboim,Bianca Simoneeng2009-01-05T00:00:00Zoai:scielo:S1676-26492008000300009Revistahttp://epilepsia.org.br/publicacoes/ONGhttps://old.scielo.br/oai/scielo-oai.php||jecnpoa@terra.com.br1980-53651676-2649opendoar:2009-01-05T00:00Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)false
dc.title.none.fl_str_mv Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
title Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
spellingShingle Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
Liberalesso,Paulo Breno Noronha
Subclinical discharges
Landau-Kleffner Syndrome
speech delay
title_short Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
title_full Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
title_fullStr Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
title_full_unstemmed Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
title_sort Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
author Liberalesso,Paulo Breno Noronha
author_facet Liberalesso,Paulo Breno Noronha
Nascimento,Lincoln Franscisco
Klagenberg,Karlin Fabianne
Jurkiewicz,Ari Leon
Zeigelboim,Bianca Simone
author_role author
author2 Nascimento,Lincoln Franscisco
Klagenberg,Karlin Fabianne
Jurkiewicz,Ari Leon
Zeigelboim,Bianca Simone
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Liberalesso,Paulo Breno Noronha
Nascimento,Lincoln Franscisco
Klagenberg,Karlin Fabianne
Jurkiewicz,Ari Leon
Zeigelboim,Bianca Simone
dc.subject.por.fl_str_mv Subclinical discharges
Landau-Kleffner Syndrome
speech delay
topic Subclinical discharges
Landau-Kleffner Syndrome
speech delay
description INTRODUCTION: Landau-Kleffner Syndrome is a rare epileptic syndrome characterized by the association of receptive aphasia, epileptic seizures, behavioral disorders and electroencephalographic changes with discharges at the temporal lobe unilaterally or bilaterally. Seizures are not essential for diagnosis. CASE REPORT: J. V. S. S., 3 y/o male, with delay in acquirement of speech, psychomotor agitation and sleep disorder (sleeplessness). Attempt to communicate was established by gestures and pointing at things. His behavior characterized by agitation, restlessness, aggressiveness and difficulty to establish social contact with other children by the same age. MRI was normal and the EEG showed sharp-wave discharges in the left medial and posterior temporal regions. After three months of treatment with carbamazepine the child returned to an evaluation, presenting substantial improvement at speech, speaking simple words and with meaningful improvement on both behavioral and sleep patterns, as well as, social interaction. DISCUSSION: Expression and reception speech disorders are relatively common in children with different epileptic syndromes, particularly in Landau-Kleffner syndrome. Epileptiform discharges can occur in people without epilepsy and use to be called subclinical discharges. What would be the impact of subclinical discharges on this population remains uncertain at the present time. We reviewed these interactions in the light of a representative case, showing favorable outcome following introduction of an antiepileptic drug.
publishDate 2008
dc.date.none.fl_str_mv 2008-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1676-26492008000300009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Liga Brasileira de Epilepsia (LBE)
publisher.none.fl_str_mv Liga Brasileira de Epilepsia (LBE)
dc.source.none.fl_str_mv Journal of Epilepsy and Clinical Neurophysiology v.14 n.3 2008
reponame:Journal of epilepsy and clinical neurophysiology (Online)
instname:Liga Brasileira de Epilepsia (LBE)
instacron:LBE
instname_str Liga Brasileira de Epilepsia (LBE)
instacron_str LBE
institution LBE
reponame_str Journal of epilepsy and clinical neurophysiology (Online)
collection Journal of epilepsy and clinical neurophysiology (Online)
repository.name.fl_str_mv Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)
repository.mail.fl_str_mv ||jecnpoa@terra.com.br
_version_ 1754734659502080000